Table 1.

Review of human immunodeficiency virus-1 infection and non-severe clinical malaria incidence

First author, year	Risk of symptomatic malaria	Remarks
Witworth, 2000 [34]	OR: 6.0, 3.4 and 1.2 for CD4 cell counts of <200/μL, 200–499/μL, and ≥500/μL, respectively	Any symptomatic parasitaemia
French, 2001 [35]	Absolute Risk: 140, 93 and 57 per 1000 person-years for CD4 cell counts of <200/μL and 200–499/μL, and ≥500 parasites/μL, respectively	Any symptomatic parasitaemia
French, 2001 [35]	Absolute Risk: 90, 53 and 22 per 1000 person-years for CD4 cell counts of <200/μL, 200–499/μL and ≥500/μL, respectively	Symptomatic parasitaemia with >2800 parasites/μL
Laufer, 2006 [37]	Relative risks of 4.4 and 3 for CD4 cell counts of <200/μL and 200–499/μL, respectively, as compared with a CD4 cell count of ≥500/μL
Patnaik, 2005 [36]	OR: 5.4, 4.9 and 3.2 per 1000 person-years for CD4 cell counts of <200/μL and 200–499/μL, and ≥400 parasites/μL, respectively	CD4 measures at baseline